A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 3/24/2010

Posted by | 4:35pm on Wednesday, March 24, 2010

:
Welcome to the marketing & social media pharma chat (#socpharm). Plse start w/intros & why u are interested in this topic. 3/24/2010 19:01

:
I’m VERY interested in the topic. I’m studying the use of SM by Spanish pharma #socpharm 3/24/2010 19:03

:
I’m Eileen & I work at Siren Interactive where we work on chronic rare disorder therapies. Fascinated by sm & use for pts & HCPs #socpharm 3/24/2010 19:04

:
@ Welcome to #socpharm! 3/24/2010 19:04

:
We’ll assume that all tweets within #socpharm are your own and not your employers (unless you specifically declare them) 3/24/2010 19:05

:
Q1: What do you think of the health care reform bill just signed? #socpharm 3/24/2010 19:07

:
Health care reform bill is awesome change that will make me sleep better after my son graduates college! #socpharm 3/24/2010 19:08

:
Q1: Most excited abt healthcare reform bill provision ending lifetime caps for patients. Amazing news for those w/ #rarediseases. #socpharm 3/24/2010 19:09

:
@ LOL. What do you think implication for pharma is? #socpharm 3/24/2010 19:10

:
RT @: Health care reform bill is awesome change that will make me sleep better after my son graduates college! #socpharm 3/24/2010 19:10

:
@ Pharma will be able to sell more drugs to more ppl cuz of HC reform bill cuz more ppl will “see ur doctor”! #socpharm 3/24/2010 19:11

:
RT @: Health care reform bill is awesome change that will make me sleep better after my son graduates college! #socpharm 3/24/2010 19:11

:
@ What do you think of hc reform and implication for pharma? #socpharm 3/24/2010 19:12

:
@ What are they saving in Spain about US healthcare reform bill? #socpharm 3/24/2010 19:13

:
@ Well it gives pharma an additional 10 million customers right away but pharma had to put big $ on table #socpharm 3/24/2010 19:14

:
RT @: Health Care Reform Reactions From Around The World http://huff.to/aBmK7C #socpharm 3/24/2010 19:16

:
It will certainly change some rules of the lobbying game for pharma companies and forcing them to leverage bottom line differently #socpharm 3/24/2010 19:16

:
@ Just asking someone from Spain on #socpharm about that topic! 3/24/2010 19:16

:
Actually, that’s why I posted it — forgot 2 tag u RT @: @ Just asking someone from Spain on #socpharm about that topic! 3/24/2010 19:17

:
@ What are they saying in France about US healthcare reform bill? #socpharm 3/24/2010 19:18

:
@ Pharma’s outlay is spread over 10 yrs whereas it gains almost immediately! I think sales will inc by more than $8 Bn/yr #socpharm 3/24/2010 19:21

:
@ Yes, but everyone must think of themselves first. Does HC reform it benefit you? #socpharm 3/24/2010 19:22

:
Q2 Amazing @ report: More than half of epatients w/chronic disease consume user-generated health info bit.ly/9GN66P #socpharm 3/24/2010 19:22

:
Q2: Will large number of chronic disease pts using social media spur pharma to use social media more? #socpharm 3/24/2010 19:23

:
@ Agreed that is why the Street loves pharma stocks now but the real winners are American public once they see it #socpharm 3/24/2010 19:25

:
In France, the reform is applaused, approaching our own system. But it may have been better (drug price fixing / reimportation) #socpharm 3/24/2010 19:25

:
Q2 Hi Eileen. Are pts the real customers of pharma? Doesn’t pharma traditionally see docs as their customers? So maybe… #socpharm 3/24/2010 19:26

:
Join @ @: “What S-A Learned from Its FB Experience” Tues Apr 6, 2 PM: http://bit.ly/acxIzh #fdaSM #hcsmeu #socpharm 3/24/2010 19:27

:
@ Q2: Good point, I was w/ @ this week which made me forget about HCPs for a minute there :) #socpharm 3/24/2010 19:28

:
Q2 My guess is we’ll see pharma using social nets to communicate w/ physicians, not patients. SocNets replace/supplement reps. #socpharm 3/24/2010 19:28

:
@ Q2 Empowered patients & patient POV is becoming increasingly important to pharma #socpharm 3/24/2010 19:28

:
@ at #eMarketing event @ of Within3 gave gr8 presentation abt using social media for HCPs & augmenting reps #socpharm 3/24/2010 19:31

:
chronic disease are perfect for storytelling (living pain daily forces to talk), and so, perfect for patient-generated-content. #socpharm 3/24/2010 19:32

:
Pharma companies should definitely take a deeper look into what is being said in SM at least for mktg & clinical research purposes #socpharm 3/24/2010 19:33

:
@ Right, even if pharma can’t/won’t join in the conversation at least listen #socpharm 3/24/2010 19:34

:
@ We can look fwd to more “chronic” diseases being invented. Eg, DSM re-edit, RLS, SAD, etc. SM will aid & abet #socpharm 3/24/2010 19:35

:
As a patient, benefits of understanding that a side effect of a drug is common can alleviate fears and concerns & + compliance #socpharm 3/24/2010 19:35

:
#socpharm 3/24/2010 19:37

:
@ Plus sm can provide useful tips on avoiding/coping w/drug side effects #socpharm 3/24/2010 19:37

:
@ Do you think pt to pt nets can have a positive impact on medication adherence/persistence/compliance? #socpharm 3/24/2010 19:37

:
@ true, a conversation benefits patients & the manufacturers of a medication- will be good for this to become reality #socpharm 3/24/2010 19:39

:
@ @ RU saying that PtoP nets can overcome pt fears based on adverse effect disclosures? #socpharm 3/24/2010 19:39

:
@ Pharma comp famous cold feet will help avoiding any new “chronic” disease creation. They will engage as silent observer #socpharm 3/24/2010 19:39

:
side effects and adverse events are not the same thing @ #socpharm 3/24/2010 19:40

:
Q3: In recent NORD & @ study 58% of rare disease pts said community participation improved health: http://bit.ly/a5w4Lb #socpharm 3/24/2010 19:41

:
@ Granted. I’m talking about the mandated print/audio side/possible adverse effect warnings. #socpharm 3/24/2010 19:41

:
@ Positive impact? Sure! I can’t see any reason why “wisdom of crowds” can not be applied to patients networks. #socpharm 3/24/2010 19:41

:
@ If U look at pharma comments to #fdaSM, most anticipate “joining the conversation,” not just monitoring it. #socpharm 3/24/2010 19:41

:
Q3: Anyone know any scientific research being done re online community participating have measurable health impact? #socpharm 3/24/2010 19:44

:
Q3: Do remember seeing some past studies from Brown re online weight loss supporting having minor impact. Any others? #socpharm 3/24/2010 19:45

:
@ Will they really do it? I hope. But they will suddenly face a lot of messages to reply/react/address in a few days. #socpharm 3/24/2010 19:46

:
@ interesting I have read that difficult to measure those participating vs patients who are well and have moved on #socpharm 3/24/2010 19:46

:
@ Observing and internal training first would be a wiser step, to avoid any maelstrom like the SA or the Motrin J&J ones #socpharm 3/24/2010 19:47

:
@ Good point, guess that’s why chronic patients are perfect audience. Did you see @ data? #socpharm 3/24/2010 19:48

:
@ and if they are smart they will leverage tech to manage the inflow so that the response is in real time..or close. #socpharm 3/24/2010 19:49

:
@ thanks- definitely an interesting study on chronic patients and the internet from Pew #socpharm 3/24/2010 19:50

:
@ Obviously pharma is going to need to hire a lot of “community mgrs.” I recommend @! http://bit.ly/aUpGMV #socpharm 3/24/2010 19:51

:
@ The Duchenne Community might interest you: http://www.duchenne-community.com/ #socpharm 3/24/2010 19:52

:
@ @ @ Just learned about this chronic pain forum http://is.gd/aXv9B #socpharm 3/24/2010 19:52

:
Maybe former sales reps RT @: @ Obviously pharma is going to need to hire a lot of “community mgrs.” #socpharm 3/24/2010 19:52

:
ROFL! RT @: @ Q2: Good point, I was w/@epatientdave this week – made me forget about HCPs for a minute :) #socpharm 3/24/2010 19:52

:
@ Fascinating, thanks for sharing. #socpharm 3/24/2010 19:54

:
@ Pharmas have enough people internally to perform the task. But they need a technology upgrade! ;-) @ can help! #socpharm 3/24/2010 19:54

:
@ Ha Ha! Former sales reps as SM community managers! That’s hilarious. See CafePharma #socpharm 3/24/2010 19:54

:
Great @ Here is a neurology web forum from Mass Gen that has been around forever http://bit.ly/cPrUQD #socpharm 3/24/2010 19:55

:
@ @ With proper training, existing teams can become brand advocates and make the comm mgmt task easier! #socpharm 3/24/2010 19:56

:
@ @ I was actually serious. There are lots of gr8 pharma sales reps who are looking for work. #socpharm 3/24/2010 19:58

:
@ @ That’s why preventing pharma people to use SM at work is not helping, but only blindfolding them #socpharm 3/24/2010 19:58

:
@ What pharma needs r NOT brand advocates but PATIENT advocates to mgr their SM engagement! #socpharm 3/24/2010 19:59

:
@ Well @ recently took down their internal ban of Facebook access. #socpharm 3/24/2010 19:59

:
Note next Wed (last Wed of quarter) #socpharm will be in the morning (for US folks) at 8 AM est so more EU tweeps can take part. 3/24/2010 20:00

:
@ Seriously, reps would be great advocates of their brands. Isn’t it their daily job after all? #socpharm 3/24/2010 20:00

:
@ I think pharma need BOTH brand and patients advocates. It’s better for fueling constructive conversations. #socpharm 3/24/2010 20:02

:
@ @ does have a point about proper training to ensure a patient-focus. #socpharm 3/24/2010 20:02

:
Thanks for everyone who joined in #socpharm tonight — hope to see you next Wednesday at 8 AM est. 3/24/2010 20:03

:
Looking forward to hearing @ talk to @ about SA & Facebook on Tue: http://bit.ly/arevmd #socpharm 3/24/2010 20:04

:
Thanks everyone for the tweetup and thanks to EileenOBrien for curating it! Looking forward to our next conversations! #socpharm 3/24/2010 20:05

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com